 <h1>Ranexa Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>ranolazine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about ranolazine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Ranexa.</p><h2>In Summary</h2><p><b>More frequent side effects include:</b> constipation, dizziness, and nausea.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to ranolazine: oral tablet extended release</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, ranolazine (the active ingredient contained in Ranexa) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking ranolazine:</p><p>
<i>More common</i>
</p><ul>
<li>Dizziness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>continuous ringing or buzzing or other unexplained noise in the ears</li>
<li>difficult or labored breathing</li>
<li>fast, irregular, pounding, or racing heartbeat or pulse</li>
<li>feeling of constant movement of self or surroundings</li>
<li>hearing loss</li>
<li>lightheadedness</li>
<li>rapid weight gain</li>
<li>sensation of spinning</li>
<li>tightness in the chest</li>
<li>tingling of the hands or feet</li>
<li>unusual weight gain or loss</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Abnormal or decreased touch sensation</li>
<li>agitation</li>
<li>blood in the urine</li>
<li>blurred vision</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>chest pain or discomfort</li>
<li>chills</li>
<li>cold sweats</li>
<li>coma</li>
<li>confusion</li>
<li>decreased urine output</li>
<li>depression</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>fainting</li>
<li>headache</li>
<li>hostility</li>
<li>irritability</li>
<li>lethargy</li>
<li>muscle twitching</li>
<li>nausea</li>
<li>seizures</li>
<li>shakiness in the legs, arms, hands, or feet</li>
<li>slow or irregular heartbeat</li>
<li>stupor</li>
<li>sweating</li>
<li>trembling or shaking of the hands or feet</li>
<li>unusual tiredness or weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of ranolazine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Difficulty having a bowel movement (stool)</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Dry mouth</li>
<li>stomach pain</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Lack or loss of strength</li>
</ul><p>
<!-- end oral tablet extended release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ranolazine: oral tablet extended release</i></p><h3>General</h3><p>The most common adverse reactions were dizziness, headache, constipation, and nausea.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, nausea, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Abdominal pain, dry mouth, dyspepsia, flatulence, stomach discomfort</p>
<p><b>Rare</b> (less than 0.1%): Pancreatitis, erosive duodenitis, oral hypoesthesia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, headache</p>
<p><b>Uncommon</b> (0.1% to 1%): Lethargy, syncope, hypoesthesia, somnolence, tremor, postural dizziness, paresthesia, vertigo, tinnitus</p>
<p><b>Rare</b> (less than 0.1%): Amnesia, depressed level of consciousness, loss of consciousness, coordination abnormal, gait disturbance, parosmia</p>
<p><b>Postmarketing reports</b>: Myoclonus<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia</p>
<p><b>Uncommon</b> (0.1% to 1%): Fatigue, peripheral edema</p>
<p><b>Rare</b> (less than 0.1%): Impaired hearing<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Anorexia, appetite decreased, dehydration, weight decreased</p>
<p><b>Rare</b> (less than 0.1%): Hyponatremia</p>
<p><b>Postmarketing reports</b>: Hypoglycemia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Anxiety, insomnia, confusional state, hallucination</p>
<p><b>Rare</b> (less than 0.1%): Disorientation<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Pain in extremity, muscle cramp, joint swelling, muscular weakness<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Hot flush, hypotension, prolonged QT corrected interval</p>
<p><b>Rare</b> (less than 0.1%): Peripheral coldness, orthostatic hypotension</p>
<p><b>Frequency not reported</b>: Bradycardia, palpitations<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Dysuria, hematuria, chromaturia</p>
<p><b>Rare</b> (less than 0.1%): Urinary retention, erectile dysfunction<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Dyspnea, cough, epistaxis</p>
<p><b>Rare</b> (less than 0.1%): Throat tightness</p>
<p><b>Frequency not reported</b>: Pulmonary fibrosis<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Blurred vision, visual disturbance, diplopia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Serum creatinine increased, blood urea increased</p>
<p><b>Rare</b> (less than 0.1%): Acute renal failure</p>
<p><b>Frequency not reported</b>: Blood urea increased<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Pruritus, hyperhidrosis</p>
<p><b>Rare</b> (less than 0.1%): Angioedema, urticaria, cold sweat, rash<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Platelet or white blood cell count increased</p>
<p><b>Frequency not reported</b>: Eosinophilia, thrombocytopenia, leukopenia, pancytopenia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (less than 0.1%): Hepatic enzyme levels elevated<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Ranexa (ranolazine)." Calmoseptine Inc, Huntington Beach, CA. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Ranexa (ranolazine)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>61 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: antianginal agents</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Ranexa &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Angina</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ranolazine: oral tablet extended release</i></p><h3>General</h3><p>The most common adverse reactions were dizziness, headache, constipation, and nausea.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, nausea, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Abdominal pain, dry mouth, dyspepsia, flatulence, stomach discomfort</p><p><b>Rare</b> (less than 0.1%): Pancreatitis, erosive duodenitis, oral hypoesthesia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, headache</p><p><b>Uncommon</b> (0.1% to 1%): Lethargy, syncope, hypoesthesia, somnolence, tremor, postural dizziness, paresthesia, vertigo, tinnitus</p><p><b>Rare</b> (less than 0.1%): Amnesia, depressed level of consciousness, loss of consciousness, coordination abnormal, gait disturbance, parosmia</p><p><b>Postmarketing reports</b>: Myoclonus<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia</p><p><b>Uncommon</b> (0.1% to 1%): Fatigue, peripheral edema</p><p><b>Rare</b> (less than 0.1%): Impaired hearing<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Anorexia, appetite decreased, dehydration, weight decreased</p><p><b>Rare</b> (less than 0.1%): Hyponatremia</p><p><b>Postmarketing reports</b>: Hypoglycemia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Anxiety, insomnia, confusional state, hallucination</p><p><b>Rare</b> (less than 0.1%): Disorientation<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Pain in extremity, muscle cramp, joint swelling, muscular weakness<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Hot flush, hypotension, prolonged QT corrected interval</p><p><b>Rare</b> (less than 0.1%): Peripheral coldness, orthostatic hypotension</p><p><b>Frequency not reported</b>: Bradycardia, palpitations<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Dysuria, hematuria, chromaturia</p><p><b>Rare</b> (less than 0.1%): Urinary retention, erectile dysfunction<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Dyspnea, cough, epistaxis</p><p><b>Rare</b> (less than 0.1%): Throat tightness</p><p><b>Frequency not reported</b>: Pulmonary fibrosis<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Blurred vision, visual disturbance, diplopia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Serum creatinine increased, blood urea increased</p><p><b>Rare</b> (less than 0.1%): Acute renal failure</p><p><b>Frequency not reported</b>: Blood urea increased<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Pruritus, hyperhidrosis</p><p><b>Rare</b> (less than 0.1%): Angioedema, urticaria, cold sweat, rash<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Platelet or white blood cell count increased</p><p><b>Frequency not reported</b>: Eosinophilia, thrombocytopenia, leukopenia, pancytopenia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (less than 0.1%): Hepatic enzyme levels elevated<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Ranexa (ranolazine)." Calmoseptine Inc, Huntington Beach, CA. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about Ranexa (ranolazine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>61 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: antianginal agents</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Ranexa &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Angina</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>